Page last updated: 2024-09-03

gefitinib and belinostat

gefitinib has been researched along with belinostat in 2 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(belinostat)
Trials
(belinostat)
Recent Studies (post-2010) (belinostat)
5,2315662,91920830167
5,2315662,919807

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)belinostat (IC50)
Histone deacetylase 3Homo sapiens (human)0.1942
Bromodomain-containing protein 4Homo sapiens (human)0.027
Cytochrome P450 3A5Homo sapiens (human)0.2147
Histone deacetylase 4Homo sapiens (human)1.1602
Aspartyl/asparaginyl beta-hydroxylaseHomo sapiens (human)5.12
Histone deacetylase 1Homo sapiens (human)0.816
Histone deacetylase 7Homo sapiens (human)0.0357
Histone deacetylase 2Homo sapiens (human)0.2401
Polyamine deacetylase HDAC10Homo sapiens (human)0.0357
Histone deacetylase 11 Homo sapiens (human)1.5966
Histone deacetylase 8Homo sapiens (human)1.2526
Histone deacetylase 6Homo sapiens (human)1.1946
Histone deacetylase 9Homo sapiens (human)0.0357
Histone deacetylase 5Homo sapiens (human)0.0357
Histone deacetylase Plasmodium falciparum (malaria parasite P. falciparum)0.2147

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akashi, M; Chin, TM; Doan, NB; Koeffler, HP; Mori, S; Said, JW; Sudo, M1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

2 other study(ies) available for gefitinib and belinostat

ArticleYear
Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:5

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Gefitinib; Humans; Hydroxamic Acids; Lactams, Macrocyclic; Lung Neoplasms; Mice; Mice, Nude; Mutation; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Quinazolines; Sulfonamides; Xenograft Model Antitumor Assays

2013
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013